(Q54530926)

English

Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantation.

scientific article published on 10 February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

immunosuppression

1 reference

based on heuristic

inferred from title

Johann Pratschke

2

object named as

Johann Pratschke

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

author name string

Markus Guba

1

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

Christian Hugo

3

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

Bernhard K Krämer

4

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

Andreas Pascher

5

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

Katharina Pressmar

6

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

Oliver Hakenberg

7

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

Michael Fischereder

8

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

Jens Brockmann

9

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

Joachim Andrassy

10

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

Bernhard Banas

11

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

Karl-Walter Jauch

12

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

SMART-Study Group

13

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

publication date

10 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

Transplant International

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

25

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

4

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

416-423

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

Reduced exposure to calcineurin inhibitors in renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01432.X

21 January 2018

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01432.X

21 January 2018

Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01432.X

21 January 2018

Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01432.X

21 January 2018

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01432.X

21 January 2018

Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01432.X

21 January 2018

Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01432.X

21 January 2018

Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01432.X

21 January 2018

The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01432.X

21 January 2018

Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil in de novo cardiac transplant recipients: a randomized, multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01432.X

21 January 2018

Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01432.X

21 January 2018

Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01432.X

21 January 2018

Identifiers

10.1111/J.1432-2277.2012.01432.X

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/22320241

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54530926&oldid=1314949217"